SS Innovations International (NASDAQ: SSII) is making significant strides in the surgical robotics market, reporting strong second-quarter 2026 results and outlining an ambitious international expansion strategy. The company’s SSi Mantra surgical robotic system is gaining traction, particularly in India, where more than 50 robotic procedures were performed in a single day at Mohak Bariatrics and Robotics in Indore. This milestone underscores the system’s growing utilization and acceptance among surgeons.
Globally, SS Innovations has installed 224 SSi Mantra systems across 12 countries. During the second quarter of 2026, the company recorded a 143% year-over-year increase in robotic procedures, reflecting rapid adoption. Quarterly revenue rose 39% to $13.9 million, with system sales climbing 41% to $12.4 million. Installations reached 30 systems during the quarter, further solidifying the company’s commercial momentum.
While India remains SS Innovations’ primary commercial market, the company is actively pursuing regulatory approvals in Europe and the United States. CE marking is targeted for the end of 2026, and the FDA is now expected to complete its review of the company’s 510(k) application by the end of the first quarter of 2027. These regulatory milestones are critical for unlocking new markets and driving future growth.
Beyond geographic expansion, SS Innovations is investing in telesurgery capabilities and expanding surgeon training programs. These initiatives aim to increase utilization of the SSi Mantra system and establish the platform in additional markets. The company’s focus on innovation and accessibility positions it to compete in the global surgical robotics arena, where demand for minimally invasive procedures continues to rise.
For healthcare providers and patients, the expansion of affordable robotic surgery options could mean greater access to advanced treatments. SS Innovations’ vision to make robotic surgery more affordable and accessible aligns with broader trends in value-based care. As the company scales its operations and enters new regions, it may also intensify competition in the surgical robotics sector, potentially driving down costs and spurring further technological advancements.
Investors and industry watchers can follow SS Innovations’ progress through its newsroom at https://ibn.fm/SSII. The latest updates are also available via TechMediaWire, a specialized communications platform for technology-focused companies. TechMediaWire is part of the Dynamic Brand Portfolio @ IBN, which offers a range of services including wire distribution through InvestorWire, editorial syndication to 5,000+ outlets, and social media distribution to millions of followers. For more information on TechMediaWire’s offerings, visit TechMediaWire.
The company’s ability to execute on its regulatory and commercial plans will be key to its long-term success. With a solid foundation in India and a clear roadmap for entering developed markets, SS Innovations is well-positioned to become a significant player in the global surgical robotics industry. As healthcare systems worldwide seek cost-effective robotic solutions, the SSi Mantra system’s affordability and advanced capabilities could drive widespread adoption, ultimately benefiting patients and providers alike.
